U.S. Markets close in 6 hrs 10 mins

See what the IHS Markit Score report has to say about Autodesk Inc.

IHS Markit

Autodesk Inc

NASDAQ/NGS:ADSK

Score: Positive (99)

7 days at current score.

Upgraded from Neutral on November 3rd 2017

View full report here!

Summary


  • This company ranked positively in all 3 IHS Markit categories and the Technology sector
  • ETFs holding this stock are seeing positive inflows
  • Bearish sentiment is low
  • Economic output in this company's sector is expanding


Bearish sentiment

Short interest | Positive

Short interest is extremely low for ADSK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ADSK.

Money flow

ETF/Index ownership | Positive

ETF activity is positive. Over the last month, growth of ETFs holding ADSK is favorable, with net inflows of $23.41 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

Economic sentiment

PMI by IHS Markit | Positive

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is strong relative to the trend shown over the past year.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • News
    CNBC

    The greatest gift my father gave me were these 8 financial lessons

    The Financial Industry Regulatory Authority Foundation estimate s nearly two-thirds of Americans c a n't pass a basic financial literacy test. Schools aren't instilling financial literacy along with ABCs and the three R's, but parents can educate kids about money.

  • Intel's CEO Just Validated the AMD Data Center Processor Threat
    Business
    Motley Fool

    Intel's CEO Just Validated the AMD Data Center Processor Threat

    Once this research note was widely disseminated, AMD stock rose more than 3% during the June 11 trading session while Intel stock shed nearly 1%. Clearly, investors interpreted Krzanich's remarks as positive for AMD and negative for Intel.

  • This Struggling Company Wants to Repurchase Nearly One-Third of Its Shares
    Business
    Motley Fool

    This Struggling Company Wants to Repurchase Nearly One-Third of Its Shares

    Newell Brands (NYSE: NWL) is quickly becoming the textbook case of a failed merger. After acquiring Jarden Brands in 2015, the combined company failed to come together as a cohesive unit and many of the synergies never materialized. The result was an acrimonious public dispute between the founder of Jarden and Newell's CEO, with both men working with activist investors to consolidate control.

  • A Look at Teva’s Generic Drugs Research Pipeline
    Business
    Market Realist

    A Look at Teva’s Generic Drugs Research Pipeline

    Teva Pharmaceutical Industries (TEVA) is the largest generics pharma manufacturer in the world. In particular, the FDA is approving generics versions of branded drugs more rapidly to shift toward a more affordable healthcare structure. Teva is on track to achieve targeted cost reductions and revenue growth.

  • Finance
    CNBC

    Boeing sell-off looks like the beginning of a correction, technical analyst says

    High-flyer Boeing BA just hit an air pocket, closing out last week with its worst weekly losses since March, on worries over an escalating trade war with China. Newton Advisors technical analyst Mark Newton is urging caution on the Dow leader. Boeing's losses over the last week could mark the beginning of a short-term correction for the stock, says Newton.

  • Better Buy: Pfizer Inc. vs. Johnson & Johnson
    Business
    Motley Fool

    Better Buy: Pfizer Inc. vs. Johnson & Johnson

    Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) have been in business since the 19th century. To answer that question, you need to know about each company's growth prospects and the strength of their dividends. Pfizer's top-selling products are Lyrica and pneumococcal vaccine Prevnar 13.

  • Business
    Forbes

    Retail Check Up: JCPenney

    From what appeared to be an existential crisis to several purposeful steps, to the latest reports and news, watching JCPenney figure out how to stay relevant has proven quite the fascinating observation. JCPenney reported first-quarter earnings on May 17, which included an earnings miss and a revenue beat. On the call, Marvin Ellison, then chairman and CEO, laid out several details, including successes, projects and upcoming endeavors at the company, and much of it relies heavily on something we all relate to in one way or another: relationships.

  • Business
    Coindesk

    Bitcoin Recovery Stalls Raising Risk of Price Drop

    Bitcoin (BTC) is once more facing a drop to (or below) $6,000, with both short- and long-duration charts being aligned in favor of the bears. The cryptocurrency found acceptance above the key resistance of $6,425 (April 1 low) in the second half of last

  • JD.com CEO: Trade war would hurt a lot of American brands
    Business
    CNBC Videos

    JD.com CEO: Trade war would hurt a lot of American brands

    CNBC's Eunice Yoon discusses worries surrounding the ongoing U.S.-China trade spat.

  • Business
    TheStreet.com

    Five Attractive REITs With Yields Above 5% for Income Investors

    Real estate investment trusts are excellent investment vehicles for investors looking to generate current portfolio income. This is in large part because of the legal implications of operating as a real estate investment trust. REITs are required by law to pay out more than 90% of their net income as distributions to shareholders.

  • Forget Intel. Here Are 3 Better Chip Stocks to Buy
    Business
    Motley Fool

    Forget Intel. Here Are 3 Better Chip Stocks to Buy

    Last month, I made the decision to sell my shares of chip giant Intel (NASDAQ: INTC). Although the company is exposed to some solid growth markets, like non-volatile memory-based storage drives, data center processors, and the booming computer gaming market, I've grown frustrated with the company's stumbles around its chip manufacturing technology -- something I fear will hurt the company's competitive positioning in the coming years. Until I see some real improvements in the company's manufacturing technology and can gain confidence that Intel isn't on the verge of seeing its market share and, potentially, its gross profit margin erode meaningfully, I'm staying out of the stock.

  • News
    MarketWatch

    3 big lifestyle moves to make so you can retire early

    There were several things I did to get to the point of early retirement. Retiring early can be done at all income levels, but the more you earn the more you can sock away and the more you’ll have to fund the retirement you want.

  • Science
    Fortune

    This Retired Astronaut Says SpaceX and NASA Rockets ‘Will Never Go to Mars’

    A retired astronaut predicts that rockets developed by SpaceX, NASA, and Blue Origin won't succeed in landing human beings on Mars -- not because the technology won't work, but because the safety risks are too great. Chris Hadfield, who retired in 2013 from the Canadian Space Agency, told Business Insider he thinks the likelihood of regular missions to Mars with humans is unlikely. During a mission to the International Space Station in 2001, he helped install a mechanical arm outside the station, becoming the first Canadian to take a spacewalk.

  • Elizabeth Holmes of Theranos could face decades in prison
    Business
    Quartz

    Elizabeth Holmes of Theranos could face decades in prison

    In it, federal prosecutors neatly outline the duo’s alleged scheme to dupe investors, doctors, patients, the press, and public about the company’s “revolutionary” blood-testing technology by relying on a pile of false claims. According to Theranos, its proprietary methods and technologies carried several advantages over conventional blood testing.

  • What Energy Transfer Equity’s Current Distribution Yield Tells Us
    Business
    Market Realist

    What Energy Transfer Equity’s Current Distribution Yield Tells Us

    Energy Transfer Equity (ETE) was trading at a distribution yield of 7% as of June 14. ETE might not increase its distribution in the remaining three quarters of 2018 after a flat distribution in the first quarter. Its distribution coverage improved significantly in the first quarter after the removal of IDR (incentive distribution rights) subsidies to Energy Transfer Partners (ETP).

  • Business
    TheStreet.com

    Why GE's Stock Has Fallen 9% in the Last 30 Days

    Shares of the beleaguered industrial giant are down 9.6% in the last 30 days, despite getting a boost from investors on May 21 when the company announced an $11.1 billion deal between GE Transportation and Wabtec. The challenges in the Power segment could pose a severe risk to GE's credit rating.

  • Nunes: Will be 'hell to pay' if documents not turned over
    Politics
    Fox Business Videos

    Nunes: Will be 'hell to pay' if documents not turned over

    DOJ under deadline to release documents to Congress related to the Russia probe; Rep. Devin Nunes speaks out on 'Sunday Morning Futures.'

  • Market Sentiment Around Loss-Making Galectin Therapeutics Inc (NASDAQ:GALT)
    Business
    Simply Wall St.

    Market Sentiment Around Loss-Making Galectin Therapeutics Inc (NASDAQ:GALT)

    Galectin Therapeutics Inc’s (NASDAQ:GALT): Galectin Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease, skin disease, and cancer. The most pressing concern for investors is GALT’s path to profitability – when will it breakeven? In this article, I will touch on the expectations for GALT’s growth and when analysts expect the company to become profitable.

  • Time Warner Is Just What AT&T Needed to Take on Facebook and Google
    Business
    Motley Fool

    Time Warner Is Just What AT&T Needed to Take on Facebook and Google

    AT&T (NYSE: T) announced a new advertising and analytics division last August in anticipation of acquiring Time Warner. In the press release announcing the new business, CEO Randall Stephenson said, "Once we complete our acquisition of Time Warner Inc

  • Ford CEO Jim Hackett reveals details about how he's reinventing the 115-year-old car company (F)
    Finance
    Business Insider

    Ford CEO Jim Hackett reveals details about how he's reinventing the 115-year-old car company (F)

    Ford has developed a massive development plan for a new-mobility corridor stretching from Detroit through its revamped headquarters in Dearborn to the University of Michigan in Ann Arbor. CEO Jim Hackett is bringing his "design thinking" innovation and management approach to the task of remaking the 100-plus-year-old company. Ford has bought a huge, crumbling rail station near downtown Detroit and intends to combine it with a plan to revive the city's Corktown neighborhood to be a center of the carmaker's Smart Mobility efforts.

  • Business
    CNBC

    Dow drops 250 points as US-China trade tensions linger

    Stocks opened lower on Monday amid lingering trade tensions between the U.S. and China, the two largest economies in the world. The Dow Jones industrial average dropped 250 points, with Intel as the worst-performing stock in the index. On Friday, President Donald Trump announced that the U.S. would inflict tariffs that would impact up to $50 billion worth of Chinese goods.

  • Business
    Benzinga

    The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

    Sentiment toward biotech stocks turned neutral this week amid a lack of any major sectorwide catalysts. That said, there were wild swings in select stocks in reaction to clinical trial announcements.  Here are a few catalytic events in the upcoming

  • 3 Dividend Stocks That Are Incredibly Cheap Right Now
    Business
    Motley Fool

    3 Dividend Stocks That Are Incredibly Cheap Right Now

    While a historic run like this has been a boon to many shareholders, there is one group that has found this environment particularly challenging -- value investors. With that in mind, let's examine three dividend paying stocks that look incredibly cheap right now: Starbucks (NASDAQ: SBUX), Walt Disney (NYSE: DIS), and Apple (NASDAQ: AAPL). Early investors in Starbucks have enjoyed massive returns, as the stock has gained more than 16,000% since going public in 1992.

  • You Should Buy Alibaba Group Holding Limited (NYSE:BABA) Because Of These Reasons
    Business
    Simply Wall St.

    You Should Buy Alibaba Group Holding Limited (NYSE:BABA) Because Of These Reasons

    Today I’ve chosen to put the spotlight on Alibaba Group Holding Limited (NYSE:BABA) due to its excellent fundamentals in more than one area. BABA is a company with impressive financial health as well as a excellent growth outlook. For those interested in digger a bit deeper into my commentary, read the full report on Alibaba Group Holding here.

  • Business
    Forbes

    7 Dividend Growers That Are On Deck For July Increases

    Meanwhile, a small group of “hidden yield” stocks are quietly handing smart investors growing income streams PLUS annual returns of 12%, 17.3%, or more. See, everyone wants dividend stocks with good current yields. You have to do more work to figure out if those yields are actually supported by the company’s cash flows, earnings power, long-term business prospects, etc. You have to sift through the same company’s history to determine how long it’s been paying those dividends.